BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanda Y, Shigeno K, Matsuo H, Yano M, Yamada N, Kumagami H. Interferon-induced sudden hearing loss. Audiology 1995;34:98-102. [PMID: 8561688 DOI: 10.3109/00206099509071903] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Arts HA. Sensorineural Hearing Loss in Adults. Cummings Otolaryngology - Head and Neck Surgery. Elsevier; 2010. pp. 2116-30. [DOI: 10.1016/b978-0-323-05283-2.00150-6] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
2 Mendes-Corrêa MC, Bittar RS, Salmito N, Oiticica J. Pegylated interferon/ribavirin-associated sudden hearing loss in a patient with chronic hepatitis C in Brazil. Braz J Infect Dis 2011;15:87-9. [PMID: 21412597 DOI: 10.1016/s1413-8670(11)70147-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
3 Zittoon RF, Madian YT, Alhennawi DEM, Nadeem HS. Cochlear Changes Caused by Peginterferon α-2b. J Interferon Cytokine Res 2018;38:311-6. [PMID: 30016180 DOI: 10.1089/jir.2018.0012] [Reference Citation Analysis]
4 Formann E, Stauber R, Denk DM, Jessner W, Zollner G, Munda-Steindl P, Gangl A, Ferenci P. Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin. Am J Gastroenterol 2004;99:873-7. [PMID: 15128353 DOI: 10.1111/j.1572-0241.2004.30372.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
5 Shin MK, Kim TH, Ju K, Ha CY, Min HJ, Jung WT, Lee OJ. A case of sudden-onset hearing loss in a patient treated with peginterferon α-2b and ribavirin for chronic hepatitis C. Korean J Hepatol 2009;15:370. [DOI: 10.3350/kjhep.2009.15.3.370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
6 Stübgen J. Interferon alpha and neuromuscular disorders. Journal of Neuroimmunology 2009;207:3-17. [DOI: 10.1016/j.jneuroim.2008.12.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
7 Mehmet A, Yilmaz N, Zorludemir S, Güleryüz A, Acoskun B, Haciyakupoglu GM. Interferon-alpha2b may impair myelinization of rat optic nerve. Adv Ther 2006;23:23-32. [PMID: 16644604 DOI: 10.1007/BF02850343] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Piekarska A, Jozefowicz-korczynska M, Wojcik K, Berkan E. Sudden hearing loss in chronic hepatitis C patient suffering from Turner syndrome, treated with pegylated interferon and ribavirin: Hipoacusia súbita en un paciente con síndrome de Turner y hepatitis crónica C tratado con interferón pegilado y ribavirina. International Journal of Audiology 2009;46:345-50. [DOI: 10.1080/14992020701261413] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
9 Elloumi H, Houissa F, Hadj NB, Gargouri D, Romani M, Kharrat J, Ghorbel A. Sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment. World J Gastroenterol 2007; 13(40): 5411-5412 [PMID: 17879419 DOI: 10.3748/wjg.v13.i40.5411] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
10 Cadoni G, Marinelli L, De Santis A, Romito A, Manna R, Ottaviani F. Sudden hearing loss in a patient hepatitis C virus (HCV) positive on therapy with alpha-interferon: a possible autoimmune-microvascular pathogenesis. J Laryngol Otol 1998;112:962-3. [PMID: 10211222 DOI: 10.1017/s0022215100142197] [Cited by in Crossref: 28] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
11 Liu J, Chen H, Lin X, Yi J, Ye W, Wei F, Zhu X, Huang J, Su J. Age-related Activation of Cyclic GMP-AMP synthase-Stimulator of Interferon Genes Signaling in the Auditory System is Associated with Presbycusis in C57BL/6J Male Mice. Neuroscience 2022;481:73-84. [PMID: 34848262 DOI: 10.1016/j.neuroscience.2021.11.031] [Reference Citation Analysis]
12 Akyol MU, Sarac S, Akyol G, Atac A, Poyraz A, Belgin E, Turan E. Investigation of the Ototoxic Effects of Interferon α2A on the Mouse Cochlea. Otolaryngol Head Neck Surg 2001;124:107-10. [DOI: 10.1067/mhn.2001.112312] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
13 Le V, Bader T, Fazili J. A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone. Nat Rev Gastroenterol Hepatol 2009;6:57-60. [DOI: 10.1038/ncpgasthep1317] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
14 Johnson K, Sargent LA, Galizio C, Ubogu EE. Interferon-α-2b/ribavirin-induced vestibulocochlear toxicity with dysautonomia in a chronic hepatitis C patient: . European Journal of Gastroenterology & Hepatology 2008;20:1110-4. [DOI: 10.1097/meg.0b013e3282f8e583] [Cited by in Crossref: 10] [Article Influence: 0.7] [Reference Citation Analysis]
15 Coffin AB, Boney R, Hill J, Tian C, Steyger PS. Detecting Novel Ototoxins and Potentiation of Ototoxicity by Disease Settings. Front Neurol 2021;12:725566. [PMID: 34489859 DOI: 10.3389/fneur.2021.725566] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wong VK, Cheong-Lee C, Ford JAE, Yoshida EM. Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: Outcome after resumption of therapy. World J Gastroenterol 2005; 11(34): 5392-5393 [PMID: 16149154 DOI: 10.3748/wjg.v11.i34.5392] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
17 Kaygusuz I, Oztürk Kaygusuz T, Oztürk A, Kiliç SS, Karlidağ T, Keleş E, Yalçin S. Effects of interferon-alpha2b on hearing. Int J Audiol 2004;43:438-41. [PMID: 15643736 DOI: 10.1080/14992020400050055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
18 Sharifian MR, Kamandi S, Sima HR, Zaringhalam MA, Bakhshaee M. INF- α and ototoxicity. Biomed Res Int 2013;2013:295327. [PMID: 23984336 DOI: 10.1155/2013/295327] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
19 Jain S, Midha V, Sood A. Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy. Indian J Gastroenterol 2011;30:239-40. [DOI: 10.1007/s12664-011-0126-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
20 Görür K, Kandemir O, Unal M, Ozcan C. The effect of recombinant interferon alpha treatment on hearing thresholds in patients with chronic viral hepatitis B. Auris Nasus Larynx. 2003;30:41-44. [PMID: 12589849 DOI: 10.1016/S0385-8146(02)00063-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
21 Little C, Cosetti MK. A Narrative Review of Pharmacologic Treatments for COVID-19: Safety Considerations and Ototoxicity. Laryngoscope 2021;131:1626-32. [PMID: 33491234 DOI: 10.1002/lary.29424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
22 Casale M, Mazzarelli C, Vespasiani Gentilucci U, Potena M, Pappacena M, Faiella F, Galati G, Salvinelli F, Picardi A. Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C. Int J Immunopathol Pharmacol 2012;25:551-6. [PMID: 22697091 DOI: 10.1177/039463201202500229] [Reference Citation Analysis]
23 Eser Karlidag G, Karlidag T, Demirdag K, Keles E. The effects of pegylated interferon/lamivudine therapy on auditory functions in patients with chronic hepatitis B. Auris Nasus Larynx 2011;38:312-8. [PMID: 21216118 DOI: 10.1016/j.anl.2010.10.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]